DIA 2019 Global Annual Meeting has ended

Create Your Own Event

DIA 2019 Global Annual Meeting

9:00am PDT

SC27: #27: eCOA 101: The What, Why, and How of eCOA to Reduce Barriers to Adoption in Clinical Studies Room 4

11:00am PDT

#107: Emerging Technologies in Clinical Research Room 11A #111: PhactMI Benchmarking Survey Highlights: How are the Twenty Seven Member Companies Executing on Medical Information Initiatives Room 4 #112: Collecting Better Patient Experience Data: Lessons Learned from Patient Organizations Room 5AB #119: Making Value-Based Contracting Stick Room 11B #120: FDA Payer Communication Guidance, Twenty Years in the Making: Now What? Room 14B

2:15pm PDT

#142: Show Me the Money! Patient and Caregiver Roles and Compensation in Research, Development, and Innovation Room 5AB #143: Opportunities and Challenges with First-In-Human Multiple Expansion Cohort Designs in Oncology Room 2 #145: Examining Essential Elements of Vendor Governance and Comparing Perspectives of Large and Emerging Biopharma Room 17AB

3:30pm PDT

#154: Current Initiatives on Patient Involvement in the Medicinal Product Lifecycle: CIOMS XI Room 6C #157: A Large Academic Medical Center’s Perspective on Using Precision Medicine to Find Patient Disease Subgroups at Scale Room 11A #163: Strategic Integration: Is Anyone Getting it Right? Room 15AB #165: Drug Development Tools in a Digital Era Room 6F #166: Updates on China Regulatory Reform Room 6E #169: How Statistics Can Help Improve Data Quality: ICH E6 R2 Room 3

8:00am PDT

#202: Updates and Lessons Learned from Novel Approaches to Pharmacovigilance Collaboration Room 6D #201: To Err is Human: Progress and Challenges in the Prevention of Medication Errors Room 6C #203: eConsent Done Right Room 11A #206: Single Source of Truth, Integrations, or IoT (Internet of Things): Exploring Ways to Improve Connectedness of Clinical Data Room 1AB

10:30am PDT

#228: Emerging Safety Challenges in New Oncology Treatments Room 6D #229: An Industry Collaboration on Pharmacovigilance Analytics Room 6C #233: Creating Clarity: Changes at CDISC to Make Standards Implementation Easier for all Stakeholders Room 1AB #241: PMDA Town Hall Room 6E #242: Use of Real World Evidence to Support Regulatory Decision-Making: First-Year Findings From the RCT-DUPLICATE Project Room 6B #245: Artificial Intelligence Enhanced Data Analytics for Clinical Trials Room 3 #246: How Employers are Reinventing Healthcare and What it Means for Research Participation and Evidence Room 14B

2:00pm PDT

#255: Pharma and Regulatory Perspectives on Machine Learning Applications in Pharmacovigilance Room 6C #264: Immuno-Oncology Product Development: Overcoming Scientific and Regulatory Challenges Room 2 #269: Driving Complex Generics to Approval: What are the Keys to Success Room 6F #271: Master Protocols: Applications in Oncology Room 3 #272: Aligning Facilitated Regulatory and Access Pathways: Observations from the North American Experience Room 14B

4:15pm PDT

#281: Structured Evidence Planning, Production, and Evaluation (SEPPE): A “Quality-Based” Framework for Drug Development Room 6C #282: The Elephant in the Room: Meaningful Communication of Near Synonyms as Suspected Adverse Reactions Room 6D #286: The Machines are Here! Learn About Real Uses of Machine Learning and Artificial Intelligence in Pharma Room 1AB #296: Informing Development and Authorizations Using Real World Evidence/Artificial Intelligence Room 6E

8:00am PDT

#301: So Much Data, So Little Time: Hot Topics in Benefit-Risk Assessment Room 6C #306: Methods for Integrating EHR Data into EDC and eSource Databases Room 1AB #310: Project Planning 101: Turning Strategy into Execution Room 15AB #314: Medical Devices: EU Medical Device Regulation, PMDA Updates, and US MDUFA IV – Where Are We Now? Room 6F #313: Model Integrated Evidence as Pivotal Information for Drug Regulatory Decision Making: When, Where, and Why Room 6E #316: Implementation of Innovative and Adaptive Designs in Clinical Trials Room 3

10:30am PDT

#327: Digital Risk Minimization: The “Next Generation” Risk Management Tools Room 6C #340: Digital Technology Advances Labeling Management and Patient Access Room 6F

2:00pm PDT

#356: Involving Patients in Medicinal Product Benefit-Risk Communication: How're We Doing? Room 6D #360: Identification of Medicinal Products: FDA's Perspective and Approach Room 1AB #363: Neurodegenerative Diseases: Early-Stage Challenges and Optimal Models in Drug Development Room 2 #369: User-Fee Programs Myth Busting: General Financial Principles Explained Room 6E

4:15pm PDT

#379: From Trials to Real World: How Safety Protocols Impact REMS Room 6C #381: A New Path Forward for Using Decentralized Clinical Trials Room 10 #385: The Importance of Human Translation for Successful Preclinical Drug Discovery and Cardiac Safety Room 2 #391: Real World Evidence and Artificial Intelligence to Inform Post-Authorization Studies Room 16AB #389: Transparency, Expanded Access Navigator, Right to Try: Helping Patients Get Access to Investigational Medicines? Room 6B #396: Challenges to Access: Bringing Payers to the Table Room 14B